Konsenzus manažmentu párov
s poruchami plodnosti
pre klinickú prax

Schválený Slovenskou gynekologicko – pôrodníckou spoločnosťou



  • F. Zegers-Hochschild, G.D. Adamson, J. de Mouzon, O. Ishihara, R. Mansour, K. Nygren, E. Sullivan, and S. van der Poel on behalf of ICMART and WHO, The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009, Human Reproduction, Vol.24, No.11 pp. 2683–2687, 2009 Fertility: assessment and treatment for people with fertility problems (update), 2012 National Collaborating Centre for Women’s and Children’s Health
  • F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol and C.B. Lambalk. A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update, Vol.12, No.6 pp. 685–718, 2006
  • J. Boivin, L. Bunting, J.A. Collins, K. G. Nygren. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Human Reproduction Vol.22, No.6 pp. 1506–1512, 2007
  • L. Oakley, P. Doyl, N. Maconochie. Lifetime prevalence of infertility and infertility treatment in the UK: results from a population-based survey of reproduction. Human Reproduction Vol.23, No.2 pp. 447–450, 2008
  • J. A. Collins, A. Van Steirteghem. Overall prognosis with current treatment of infertility. Human Reproduction Update, Vol.10, No.4 pp. 309–316, 2004
  • M.J.C. Eijkemans, A.M.E. Lintsen, C.C. Hunault, C.A.M. Bouwmans, L. Hakkaart, D.D.M. Braat, J.D.F. Habbema. Pregnancy chances on an IVF/ICSI waiting list: a national prospective cohort study. Human Reproduction Vol.23, No.7 pp. 1627–1632, 2008
  • A.K. Schröder, A. Katalinic, K. Diedrich, M. Ludwig. Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reproductive BioMedicine Online Vol 8. No 5. 2004 600-606
  • A.M. Stolwijk, et al. Cumulative probability of achieving an ongoing pregnancy aftre in-vitro fertilization and introcytoplasmic sperm injection according to a woman´s age, subfertility diagnosis and primary or secondary subfertility. Human Reprod. 2000; Vol. 15(1):203-209.
  • K. Olivius, et al. Cumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil. & Steril. 2002; Vol. 77(3):505-510.
  • J. Roest, et al. Cumulative pregnancy rates and selective drop-out of patients in in-vitro fertilization treatment. Human Reprod. 1998; Vol. 13(2):339–341.
  • C.A. Croucher CA, et al. Predictive value of the results of first in-vitro fertilization cycle on the outcome of subsequent cycles. Human Reprod. 1998; Vol. 13(2):403-408.
  • M. Brandes, et.al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Human Reproduction, Vol.24, No.12 pp. 3127–3135, 2009
  • J.A.Land, et.al.. Patient dropout in an assisted reproductive technology program: implications for pregnancy rates. Fertil. & Steril. 1997; Vol. 68(2):278-281.
  • M. Rajkhowa M, et al.. Reasons for discontinuation of IVF treatment: a questionnaire studyHuman Reprod. 2006; Vol. 21(2):358–363.
  • Názory a klinická prax slovenských gynekológov v súvislosti s neplodnosťou  a IVF centrami na Slovensku a v Českej republike, TNS Slovakia, 2015
  • A.La Marca, S. K. Sunkara. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Human Reproduction Update, Vol.20, No.1 pp. 124–140, 2014
  • Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77–83.
  • M. F. Mutlu, M. Erdem, A. Erdem, S. Yildiz, I. Mutlu, O. Arisoy, M. Oktem. Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. Assist Reprod Genet (2013) 30:657–665
  • N. Gleicher, A.Weghofer, D. H Barad. Defining ovarian reserve to better understand ovarian aging. Gleicher et al. Reproductive Biology and Endocrinology 2011, 9:23
  • T. S. Dominguesa, A. M. Rochaa, P.C. Serafinia. Tests for ovarian reserve: reliability and utility. Current Opinion in Obstetrics and Gynecology. 2010, 22:271–276
  • T.G. Cooper, E.Noonan, S.von Eckardstein, J. Auger, H.W. Gordon Baker, H.M. Behre, T.B. Haugen, T. Kruger, Ch. Wang, M. T. Mbizvo, K.M. Vogelsong. World Health Organization reference values for human semen. Characteristics. Human Reproduction Update, Vol.16, No.3 pp. 231–245, 2010
  • The Practice Committee of American Society of Reproductive Medicine. Use clomiphene citrate in women. Fertility & Sterility, Volume 100, Issue 2, Pages 341-348